Paper Description
Should clinicians be allowed to prescribe medicines “off label”? To answer the question, you might want to think about the following: Who are the main “stakeholders” in this policy debate? (Which groups would be affected by the outcomes of any resulting policy decision) What policy outcome does each group (broadly speaking) want? What values (more fundamental ideas about what is important) might underpin these policy preferences? Whose preferences/values do you think should be privileged? Why do you think this?

Leave a Reply

Your email address will not be published. Required fields are marked *